🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial evaluates whether early switching from modified fluorou...
Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2021-05-27
Trial ID
NCT04539808
This is a multi-center clinical study enrolling up to 50 participants. The ...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2025-06-17
Trial ID
NCT06698458
Treatments Being Tested
Surgical resection is the only potentially curative treatment for patients ...
Status
Terminated
Location
Smilow Cancer Hospital
Start Date
2017-06-26
Trial ID
NCT03099265
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of mFOLFIRINOX plus r...
Status
Recruiting
Location
Shanghai Cancer Center
Start Date
2024-01-10
Trial ID
NCT06149689
Treatments Being Tested
This randomized phase II trial studies how well combination chemotherapy (m...
Status
Unknown
Location
Southern Cancer Center PC-Mobile
Start Date
2016-12
Trial ID
NCT02839343
Treatments Being Tested
This study is being done to evaluate the safety and efficacy of adding NIS7...
Status
Terminated
Location
Brigham and Women's Hospital
Start Date
2023-01-06
Trial ID
NCT05546411
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of mFOLFIRINOX plus r...
Status
Recruiting
Location
Shanghai Cancer Center
Start Date
2024-04-01
Trial ID
NCT06249321
Treatments Being Tested
Indication : Adult patients with intermediate low or mid rectal adenocarcin...
Status
Recruiting
Location
Institut Sainte Catherine
Start Date
2024-03-26
Trial ID
NCT06402864
Treatments Being Tested
The purpose of this research study is to find out how safe and effective is...
Status
Recruiting
Location
University of Miami
Start Date
2022-10-05
Trial ID
NCT05412082
This is a prospective, randomized phase II trial. The aim of this study is ...
Status
Completed
Location
Institut Bergonié
Start Date
2016-10-13
Trial ID
NCT02676349
Treatments Being Tested